Search Results - "Kemna, M"

Refine Results
  1. 1

    High-yield cell ordering and deterministic cell-in-droplet encapsulation using Dean flow in a curved microchannel by Kemna, Evelien W M, Schoeman, Rogier M, Wolbers, Floor, Vermes, Istvan, Weitz, David A, van den Berg, Albert

    Published in Lab on a chip (21-08-2012)
    “…In this article high-yield (77%) and high-speed (2700 cells s(-1)) single cell droplet encapsulation is described using a Dean-coupled inertial ordering of…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry by Swinkels, Dorine W, Girelli, Domenico, Laarakkers, Coby, Kroot, Joyce, Campostrini, Natascia, Kemna, Erwin H J M, Tjalsma, Harold

    Published in PloS one (16-07-2008)
    “…Assays for the detection of the iron regulatory hormone hepcidin in plasma or urine have not yet been widely available, whereas quantitative comparisons…”
    Get full text
    Journal Article
  4. 4

    Valsartan/Sacubitril in Pediatric Heart Failure by Kemna, M., Hong, B., Friedland-Little, J., Albers, E., Law, Y.M.

    “…Valsartan/Sacubitril (V/S) has recently been approved by the FDA for pediatric (>1yo) heart failure. While the PANORAMA-HF trial is ongoing, encouraging…”
    Get full text
    Journal Article
  5. 5

    Label-free, high-throughput, electrical detection of cells in droplets by Kemna, Evelien W M, Segerink, Loes I, Wolbers, Floor, Vermes, István, van den Berg, Albert

    Published in Analyst (London) (21-08-2013)
    “…Today, droplet based microfluidics has become a standard platform for high-throughput single cell experimentation and analysis. However, until now no…”
    Get more information
    Journal Article
  6. 6

    Mass Spectrometry-Based Hepcidin Measurements in Serum and Urine: Analytical Aspects and Clinical Implications by Kemna, Erwin H.J.M, Tjalsma, Harold, Podust, Vladimir N, Swinkels, Dorine W

    Published in Clinical chemistry (Baltimore, Md.) (01-04-2007)
    “…Discovery of the central role of hepcidin in body iron regulation has shed new light on the pathophysiology of iron disorders. Information is lacking on newer…”
    Get full text
    Journal Article
  7. 7

    The avidity of PR3‐ANCA in patients with granulomatosis with polyangiitis during follow‐up by Kemna, M. J., Schlumberger, W., van Paassen, P., Dähnrich, C., Damoiseaux, J. G. M. C., Cohen Tervaert, J. W.

    Published in Clinical and experimental immunology (01-08-2016)
    “…Summary The objective of this study is to investigate whether the avidity of proteinase‐3‐anti‐neutrophil cytoplasmic antibody (PR3‐ANCA) changes during…”
    Get full text
    Journal Article
  8. 8

    When No VAD is the Right VAD: Medical Management of Critically Ill Infants Awaiting Heart Transplantation by Frandsen, E.L., Banker, K.A., Mazor, R.L., Law, Y.M., Kemna, M.S., Albers, E.L., Hong, B.J., Friedland, J.M., Little

    “…Infants listed for heart transplant (HTx) are at high risk for waitlist (WL) mortality. While WL mortality for children has decreased overall in the current…”
    Get full text
    Journal Article
  9. 9

    Prevalence and Risk Factors of Proteinuria in Pediatric Heart Transplantation by Frandsen, E.L., Hingorani, S.R., Jorgensen, N., Albers, E.L., Friedland-Little, J.M., Kemna, M.S., Hong, B.J., Law, Y.M.

    “…Renal dysfunction is a common complication of heart transplantation (HTx) in children that affects overall outcome. Proteinuria reflects renal glomerular and…”
    Get full text
    Journal Article
  10. 10

    Electrofusion of single cells in picoliter droplets by Schoeman, Rogier M., van den Beld, Wesley T. E., Kemna, Evelien W. M., Wolbers, Floor, Eijkel, Jan C. T., van den Berg, Albert

    Published in Scientific reports (27-02-2018)
    “…We present a microfluidic chip that enables electrofusion of cells in microdroplets, with exchange of nuclear components. It is shown, to our knowledge for the…”
    Get full text
    Journal Article
  11. 11

    Posterior Reversible Encephalopathy Syndrome (PRES) after Pediatric Heart Transplantation: A Multicenter Study by Kemna, M.S., Shaw, D., Ameduri, R., Azeka, E., Bradford, T., Jorgensen, N., Lin, K.Y., Menteer, J., Moller, T., Reardon, L., Schumacher, K., Shih, R., Stendahl, G., West, S., Wisotzkey, B., Zangwill, S.

    “…PRES is an uncommon complication of organ transplantation. Little is known about its clinical course and risk factors. We sought to examine the natural history…”
    Get full text
    Journal Article
  12. 12

    Substance use prevention program for adolescents with intellectual disabilities on special education schools: a cluster randomised control trial by Kiewik, M., VanDerNagel, J. E. L., Kemna, L. E. M., Engels, R. C. M. E., DeJong, C. A. J.

    “…Background Students without intellectual disability (ID) start experimenting with tobacco and alcohol between 12 and 15 years of age. However, data for 12‐ to…”
    Get full text
    Journal Article
  13. 13

    On chip electrofusion of single human B cells and mouse myeloma cells for efficient hybridoma generation by Kemna, Evelien W. M., Wolbers, Floor, Vermes, Istvan, van den Berg, Albert

    Published in Electrophoresis (01-11-2011)
    “…This article describes the development and full characterization of a microfluidic chip for electrofusion of human peripheral blood B‐cells and mouse myeloma…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17

    The role of increased pulmonary blood flow in pulmonary arterial hypertension by van Albada, M. E, Schoemaker, R. G, Kemna, M. S, Cromme-Dijkhuis, A. H, van Veghel, R, Berger, R. M. F

    Published in The European respiratory journal (01-09-2005)
    “…Chronic increased pulmonary blood flow is considered a pre-requisite for the induction of advanced vascular lesions in pulmonary arterial hypertension in…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Atopy, Eosinophilia, Complete Blood Count (CBC) and the Risk of Rejection in Pediatric Heart Transplant Recipients by Arbon, K, Albers, E, Law, S, Kemna, M, Permut, L, Law, Y.M

    “…Purpose Further understanding of risk factors for rejection can allow clinicians to reduce immunosuppression. CD3 lymphocytes play a central role in adaptive…”
    Get full text
    Journal Article